Jacques Gardette
Founder bei Bio Jag SAS
Vermögen: 75 Mio $ am 31.10.2023
Ursprung des Netzwerks ersten Grades von Jacques Gardette
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Brenus Pharma SAS
 Brenus Pharma SAS Miscellaneous Commercial ServicesCommercial Services Brenus Pharma SAS is a French company that has developed an allogeneic platform to generate first in class immune therapy to prevent cancer resistance over treatment. The company is based in Issoire, France. The company's technology, stc10-10, targets mss and msi-h population with a robust and validated preclinical data pack to offer an off-the-shelf technology allowing control of both time and cost of the manufacturing process. Brenus Pharma aims to harness a specific, highly potent, and durable immune response against moving targets in cancer by claiming the representativity, the antigenicity, and the immunogenicity of its solution. The company was founded by Benoit Pinteur, Jacques Gardette. The CEO is Paul Bravetti.
2
| Holding Company | Miscellaneous Commercial Services | 2 |
Bio Jag SAS
 Bio Jag SAS Investment ManagersFinance Bio Jag SAS provide investment services. The company was founded in December 11, 2006 and is headquartered in Clermont-Ferrand, France.
1
| Subsidiary | Investment Managers | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jacques Gardette
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|
Statistik
International
Sektoral
Operativ
| Chief Executive Officer | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
| Chief Operating Officer | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Florence Gardette | 1 |
| Benoit Pinteur | 1 |
| Paul Bravetti | 1 |
- Börse
- Insiders
- Jacques Gardette
- Unternehmensverbindungen
